NCT04865302

Brief Summary

This is a prospective observational pilot study investigating if skin-to-skin care (SSC) has an influence on cerebral oxygenation and perfusion measured with near-infrared spectroscopy (NIRS) compared to incubator care in ventilated preterm neonates on the first day after birth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 29, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 11, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2024

Completed
Last Updated

December 2, 2024

Status Verified

November 1, 2023

Enrollment Period

2.5 years

First QC Date

April 26, 2021

Last Update Submit

November 27, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • percent minutes of cerebral hypoxia

    After a 20 minutes washout period the time (percentage of minutes) of cerebral hypoxia (below 54%) will be calculated for intervention period "incubator phase I" over 40 minutes.

    60 minutes

  • percent minutes of cerebral hypoxia

    After a 20 minutes washout period the time (percentage of minutes) of cerebral hypoxia (below 54%) will be calculated for intervention period "SSC" over 40 minutes.

    60 minutes

  • percent minutes of cerebral hypoxia

    After a 20 minutes washout period the time (percentage of minutes) of cerebral hypoxia (below 54%) will be calculated for intervention period "incubator phase II" over 40 minutes.

    60 minutes

Secondary Outcomes (21)

  • Mean StO2

    60 minutes

  • Mean StO2

    60 minutes

  • Mean StO2

    60 minutes

  • Mean cFTOE

    60 minutes

  • Mean cFTOE

    60 minutes

  • +16 more secondary outcomes

Other Outcomes (3)

  • leukocyte count

    first 48 hours

  • C-reactive protein

    first 48 hours

  • IT-ratio

    first 48 hours

Interventions

SSCPROCEDURE

Incubator phase I: After feeding the neonates will be brought in a prone position in the incubator and the NIRS sensor will be applied on the forehead for continuous cStO2 measurements throughout the study period. The neonate will rest in this position for 60 minutes. SSC phase: The neonate will be brought on the mother's or father's chest (skin to skin) in a prone position and will stay in this position for 60 minutes. Incubator phase II: The neonates will be brought back into the incubator for another 60 minutes in prone position. After 180 minutes the study period is over and the NIRS sensor will be removed.

Eligibility Criteria

Age15 Minutes - 24 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Preterm neonates \<37+0 weeks of gestation admitted to the Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz after vaginal delivery or caesarean section will be eligible for the study.

You may qualify if:

  • Need for respiratory support (endotracheal tube \[ETT\], nasal continuous positive airway pressure \[nCPAP\], high-flow nasal cannula \[HFNC\])
  • Decision to conduct full life support
  • Written informed consent

You may not qualify if:

  • No decision to conduct full life support
  • No written informed consent
  • Severe congenital malformations, severe asphyxia (umbilical cord artery pH \<7.00)
  • Cerebral malformations, posthaemorrhagic ventricular dilatation, intraventricular haemorrhage grade III, periventricular haemorrhage
  • Cardiovascular instability (need for catecholamines)
  • No need for respiratory support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Pediatrics, Division of Neonatology, Medical University of Graz

Graz, Styria, 8036, Austria

Location

MeSH Terms

Conditions

Premature BirthBronchopulmonary Dysplasia

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVentilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Nina Höller, MD

    Medical University of Graz, Department of Paediatrics and Adolescent Medicine, Devision of Neonatology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2021

First Posted

April 29, 2021

Study Start

October 1, 2021

Primary Completion

April 11, 2024

Study Completion

April 11, 2024

Last Updated

December 2, 2024

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations